title: With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
abstract: The presence, at the time of challenge, of antiviral effector T cells in the vaginal mucosa of female rhesus macaques immunized with live-attenuated simian-human immunodeficiency virus 89.6 (SHIV89.6) is associated with consistent and reproducible protection from pathogenic simian immunodeficiency virus (SIV) vaginal challenge (18). Here, we definitively demonstrate the protective role of the SIV-specific CD8(+) T-cell response in SHIV-immunized monkeys by CD8(+) lymphocyte depletion, an intervention that abrogated SHIV-mediated control of challenge virus replication and largely eliminated the SIV-specific T-cell responses in blood, lymph nodes, and genital mucosa. While in the T-cell-intact SHIV-immunized animals, polyfunctional and degranulating SIV-specific CD8(+) T cells were present in the genital tract and lymphoid tissues from the day of challenge until day 14 postchallenge, strikingly, expansion of SIV-specific CD8(+) T cells in the immunized monkeys was minimal and limited to the vagina. Thus, protection from uncontrolled SIV replication in animals immunized with attenuated SHIV89.6 is primarily mediated by CD8(+) T cells that do not undergo dramatic systemic expansion after SIV challenge. These findings demonstrate that despite, and perhaps because of, minimal systemic expansion of T cells at the time of challenge, a stable population of effector-cytotoxic CD8(+) T cells can provide significant protection from vaginal SIV challenge.
authors.affiliation: CNPRC, UC Davis, One Shields Ave., Davis, CA 95616, USA.
authors.forename: Meritxell
authors.initials: M
authors.lastname: Genescà
authors.forename: Pamela J
authors.initials: PJ
authors.lastname: Skinner
authors.forename: Jung Joo
authors.initials: JJ
authors.lastname: Hong
authors.forename: Jun
authors.initials: J
authors.lastname: Li
authors.forename: Ding
authors.initials: D
authors.lastname: Lu
authors.forename: Michael B
authors.initials: MB
authors.lastname: McChesney
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Miller
mesh_terms: D000818:Animals; D001769:Blood / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D005260:Female; D008198:Lymph Nodes / Q000276:immunology; D008212:Lymphocyte Depletion; D008253:Macaca mulatta; D009092:Mucous Membrane / Q000276:immunology; D018449:SAIDS Vaccines / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000517:prevention & control*; D015302:Simian Immunodeficiency Virus / Q000276:immunology*; D014613:Vaccines, Attenuated / Q000276:immunology; D014621:Vagina / Q000276:immunology
chemical_list: D018449:SAIDS Vaccines; D014613:Vaccines, Attenuated
references.citation: Nat Rev Immunol. 2008 Feb;8(2):107-19
references.pmid: 18219309
references.citation: J Virol. 1994 Sep;68(9):6103-10
references.pmid: 8057491
references.citation: J Virol. 2008 Jun;82(11):5618-30
references.pmid: 18367534
references.citation: J Virol. 2000 Aug;74(16):7485-95
references.pmid: 10906202
references.citation: Clin Exp Immunol. 2002 Apr;128(1):10-20
references.pmid: 11982585
references.citation: J Virol. 2005 Jul;79(13):8131-41
references.pmid: 15956558
references.citation: Cell Mol Life Sci. 2005 Dec;62(23):2853-66
references.pmid: 16314932
references.citation: J Allergy Clin Immunol. 2008 Jul;122(1):3-9; quiz 10-1
references.pmid: 18468671
references.citation: J Exp Med. 2007 Oct 1;204(10):2473-85
references.pmid: 17893201
references.citation: AIDS. 2002 Jul 26;16(11):1489-96
references.pmid: 12131186
references.citation: J Immunol. 2002 Sep 15;169(6):3438-46
references.pmid: 12218167
references.citation: J Exp Med. 2004 Nov 15;200(10):1299-314
references.pmid: 15545355
references.citation: Mucosal Immunol. 2008 May;1(3):219-28
references.pmid: 19079181
references.citation: J Exp Med. 2006 Jun 12;203(6):1533-41
references.pmid: 16735692
references.citation: Lancet Infect Dis. 2008 Feb;8(2):82-3
references.pmid: 18060842
references.citation: AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1455-66
references.pmid: 11679158
references.citation: J Virol. 2005 Jul;79(14):9217-27
references.pmid: 15994816
references.citation: J Gen Virol. 2004 Sep;85(Pt 9):2591-2602
references.pmid: 15302953
references.citation: Virology. 2005 Mar 15;333(2):226-38
references.pmid: 15721357
references.citation: Clin Infect Dis. 2008 Jun 1;46(11):1769-81
references.pmid: 18433307
references.citation: J Virol. 1999 Jul;73(7):5466-72
references.pmid: 10364294
references.citation: Immunity. 2007 Aug;27(2):281-95
references.pmid: 17723218
references.citation: Eur J Immunol. 2000 Dec;30(12):3598-603
references.pmid: 11169402
references.citation: J Med Primatol. 2006 Aug;35(4-5):202-9
references.pmid: 16872283
references.citation: J Immunol. 2007 Oct 1;179(7):4571-9
references.pmid: 17878354
references.citation: J Virol. 2007 Oct;81(20):10861-8
references.pmid: 17670818
references.citation: J Exp Med. 2007 Jul 9;204(7):1625-36
references.pmid: 17606632
references.citation: J Immunol. 2000 Jul 15;165(2):613-7
references.pmid: 10878330
references.citation: J Virol. 2002 Jul;76(14):7187-202
references.pmid: 12072518
references.citation: J Immunol. 2007 Oct 1;179(7):4732-40
references.pmid: 17878372
references.citation: Science. 1999 Feb 5;283(5403):857-60
references.pmid: 9933172
references.citation: Science. 2008 May 9;320(5877):760-4
references.pmid: 18467582
references.citation: Virology. 2000 Jan 5;266(1):203-10
references.pmid: 10612675
references.citation: J Immunol. 2008 Apr 15;180(8):5439-47
references.pmid: 18390726
references.citation: J Exp Med. 1999 Mar 15;189(6):991-8
references.pmid: 10075982
references.citation: J Virol. 2001 Feb;75(3):1507-15
references.pmid: 11152522
references.citation: Immunol Res. 2008;40(3):235-43
references.pmid: 17989940
references.citation: J Virol. 2003 Mar;77(5):3099-118
references.pmid: 12584336
references.citation: J Immunol. 2008 Jan 1;180(1):350-60
references.pmid: 18097036
references.citation: Science. 2008 May 9;320(5877):753-5
references.pmid: 18467578
references.citation: J Virol. 2005 Dec;79(23):14986-91
references.pmid: 16282500
references.citation: Blood. 2006 Jun 15;107(12):4781-9
references.pmid: 16467198
references.citation: J Exp Med. 2000 Jul 3;192(1):63-75
references.pmid: 10880527
references.citation: J Virol. 2006 May;80(10):5074-7
references.pmid: 16641299
references.citation: J Immunol. 2004 Oct 15;173(8):5064-76
references.pmid: 15470050
references.citation: J Virol. 2005 Nov;79(22):14355-70
references.pmid: 16254370
references.citation: Annu Rev Immunol. 2003;21:515-46
references.pmid: 12500980
references.citation: Microbes Infect. 2003 Jan;5(1):59-67
references.pmid: 12593974
references.citation: N Engl J Med. 2007 Dec 27;357(26):2653-5
references.pmid: 18160684
references.citation: J Virol. 2005 Jul;79(14):9228-35
references.pmid: 15994817
references.citation: J Virol. 2003 Dec;77(24):13348-60
references.pmid: 14645590
references.citation: J Virol. 1997 Mar;71(3):1911-21
references.pmid: 9032322
references.citation: J Immunol Methods. 2002 Oct 1;268(1):29-34
references.pmid: 12213340
references.citation: J Virol. 2008 Jul;82(13):6758-61
references.pmid: 18434394
references.citation: J Virol. 1994 Jul;68(7):4650-5
references.pmid: 8207839
references.citation: J Immunol. 1998 Jun 15;160(12):6062-71
references.pmid: 9637523